NP008

Methyl B12 Plus


TAGS:    B VITAMINS    |   ENERGY PRODUCTION    |   METHYLATION SUPPORT

Biologically active form of vitamin B12 with Folate

INTRODUCTION

Cyanocobalamin is the most commonly supplemented form of vitamin B12, but this form of vitamin B12 does not actually occur in plants or animal tissues. Another available form of B12 that offers significant advantages over cyanocobalamin is called methylcobalamin. This form of B12 is called a coenzyme form of B12 and is believed to be a much more active form of the vitamin. In addition to the methylcobalamin coenzyme form, B12 is also available in another coenzyme form, which is most commonly called “adenosylcobalamin”. The adenosylcobalamin form of B12 is also occasionally called cobamamide or dibencozide.


DESCRIPTION/ BACKGROUND

Although methylcobalamin and adenosylcobalamin are both considered being active forms of B12, they do appear to offer slightly different health advantages. Compared with cyanocobalamin, it appears that both methylcobalamin and adenosylcobalamin are better absorbed and retained in higher amounts within your tissues. In simple terms, they are used much more effectively. In general, methylcobalamin is used primarily in liver, brain and nervous system, while adenosylcobalamin is used mostly in the liver and for hemoglobin (blood cell) production.



AGENT/ INGREDIENT ROLE
Vitamin B-9 (folic acid)
Methylcobalamin

TABLE 1: Key agents in Methyl B12 Plus.

ACTIONS/ INDICATIONS

Vitamin B12 (As Methylcobalamin & Adenosylcobalamin).  One of the classic indications of B12 deficiency is a specialized form of anemia called macrocytic anemia. This usually shows up on a lab test as an increased mean corpuscular volume (in other words your blood cells are a bit larger than they should be). While iron is often the only thing given for anemia, this form of anemia usually has nothing to do with a lack of iron. B12 and folic acid are the nutrients you would need, but you need them to be plugged into enzymes. Because of this, the active forms of B12 are often much more effective. Even with other forms of anemia, it is usually much more effective to combine iron supplementation with folic acid + either or both of the active forms of vitamin B12.

In animals, a significant body of experimental evidence suggests that a deficiency of vitamin B12 can enhance the activity of various carcinogens. Animal experiments have also demonstrated that both methylcobalamin and adenosylcobalamin increase survival time and reduce tumor growth in some forms of cancer. Amazingly, methylcobalamin has also been shown to enhance the effectiveness of methotrexate, a drug sometimes used in the treatment of cancer. The active forms of B12 also appear to be very important in supporting proper immune system health. While this information should not be presumed to apply to human cancer, and there is currently no available evidence indicating that any form of vitamin B12 has any benefit in preventing or treating cancer, it certainly seems that this nutrient would be worthy of some future research.

Methylcobalamin is the specific form of B12 needed for nervous system health. Because of this it should be the first form of this vitamin thought of when interested in attempting to optimize the health of the nervous system with vitamin supplementation. Indications of a potential deficiency of B12 in the nervous system might include numbness, tingling, loss of feeling sensation, burning sensations, muscle cramps, nerve pain and slowness of reflexes.

The relative balance of the nervous system is also of critical importance in the overall sense of health and well being. In essence, we have a fight or flight nervous system and a relaxation nervous system. Methylcobalamin has been shown to be an important vitamin in helping to establish and maintain an appropriate balance between these two opposing nervous systems.

Because of the importance of methylcobalamin in nervous system health, it is also an important nutrient for vision. In fact, continued visual work (like work on a computer) often leads to a reduction in something called “visual accommodation”. Methylcobalamin can significantly improve visual accommodation, while cyanocobalamin appears to be ineffective.

An elevated level of homocysteine is a metabolic indication of decreased levels of the coenzyme forms of vitamin B12, especially methylcobalamin. Homocysteine has received a tremendous amount of emphasis in the scientific literature because of its associations with heart disease and a variety of other specific health conditions have even seen advertisements on television promoting folic acid, as a vitamin needed to lower homocysteine. While this is true, and folic acid does lower homocysteine levels, the combination of methylcobalamin and folic acid appears to work much better.

In people with liver disease, although high blood levels of vitamin B12 are common, it is not unusual to actually have a correspondingly low liver tissue concentration of vitamin B12 and its enzymes. In effect, your locksmith can’t make keys anymore so the functions that depend on a complete and working B12 enzymes often suffer. Because of this, methylcobalamin and adenosylcobalamin should be the forms of B12 used under these circumstances. In fact, even under normal circumstances, the active forms of B12 help the liver function much more efficiently. Liver detoxification and antioxidant systems work much more effectively when methylcobalamin and adenosylcobalamin are supplied (as opposed to cyanocobalamin). Since our livers tend to be over worked due to the varieties of pollution and other environmental factors we are exposed to, these active forms of B12 can be valuable forms of additional nutritional support for the liver.

The most well studied use of methylcobalamin has to do with sleep. Although the exact mechanism of action is not yet clear, it is possible that methylcobalamin is needed for the synthesis of melatonin. Available information indicates that methylcobalamin can modulate melatonin secretion, enhance light- sensitivity and normalize circadian rhythm (24-hour clock). Because of this, individuals supplementing this form of B12 often have improved quality of sleep, often will require slightly less sleep, and will not uncommonly report that they feel a bit more refreshed when waking in the morning.

Methylcobalamin is particularly effective when the 24-hour clock is not running smoothly. This may be indicated by a need for excessive sleep, changing sleep-wake cycles, or a tendency to have altered sleep wake patterns. Under all of these circumstances the combination of methylcobalamin (about 3000 mcg daily) and exposure to bright light in the morning can help re-establish the 24-hour clock.

Because of methylcobalamin’s impact on 24-hour clock and the cycles that feed of this, it is also an important vitamin to regulate your 24-hour release of the stress hormone cortisol. This seems to be particularly important for blood types A and AB. Methylcobalamin also seems to result in a better 24- hour maintenance of body temperature. Typically, individuals supplementing this coenzyme form of B12 have higher temperatures in the later hours of the daytime. This usually corresponds with improved alertness at the same time of the day. While this can be of importance to all blood types, low body temperature seems to be an area of greater challenge for A’s and B’s.

Other uses of Methylcobalamin are:

  • Increase alertness and body temperature
  • May slightly help those with diabetic neuropathy. A better nutrient for this condition is lipoic acid.
  • It has been found to be helpful in Bell’s palsy
  • Methylcobalamin lowers levels of homocysteine. Methylcobalamin is the coenzymatically active form of vitamin B12 that acts as a cofactor for methionine synthase in the conversion of homocysteine to methionine.
  • Taken orally Methylocobalamin is effective in the treatment of pernicious anemia, says a Japanese study
  • It may inhibit the ototoxic (hearing damage) side effects of the antibiotic gentamicin

 

Folate (from Calcium Folinate).  There are two active forms of folate, one is folinic acid the other is L-5-methyltetrahydrofolate (5-MTHF) otherwise known as levomefolic acid. Calcium folinate is the calcium salt of folinic acid. This is an active metabolite of folate and as such does not require metabolism by dihydrofolate reductase.


TYPICAL DOSAGE

The appropriate dose of the coenzyme forms can vary, but a dose of between 1000-2000 mcg daily is usually adequate. If attempting to influence sleep cycles or your 24-hour clock a higher dose of methylcobalamin (3000 mcg daily) is usually a more prudent starting point. Both of these forms of B12 are considered to be exceptionally safe and can be used by all blood types.

PRODUCT HISTORY

This product was introduced by NAP in 2001 after first being specifically designed for use at the D’Adamo Clinic.

REFERENCES

  1. Mayer G, Kroger M, Meier-Ewert K. Effects of vitamin B12 on performance and circadian rhythm in normal subjects. Neuro- psychopharmacology 1996;15:456-464.
  2. Shimizu N, Hamazoe R, Kanayama H, et al. Experimental study of antitumor effect of methyl-B12. Oncology 1987;44:169- 173.
  3. Okuda K, Yashima K, Kitazaki T, Takara I. Intestinal absorption and concurrent chemical changes of methylcobalamin. J Lab Clin Med 1973;81:557-567.
  4. Jalaludin MA. Methylcobalamin treatment of Bell’s palsy. Methods Find Exp Clin Pharmacol 1995;17:539-544.
  5. Tsao CS, Myashita K. Influence of cobalamin on the survival of mice bearing ascites tumor. Pathology 1993;61:104-108.
  6. Miasishcheva NV, Gerasimova GK, Il’ina NS, Sof ’ina ZP. Effect of methylcobalamin on methotrexate transport in normal and tumorous tissues. Biull Eksp Biol Med 1985;99:736-738. [Article in Russian]
  7. Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 1992;94:105-111.
  8. Kikuchi M, Kashii S, Honda Y, et al. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 1997;38:848-854.
  9. Nishizawa Y, Yamamoto T, Terada N, et al. Effects of methylcobalamin on the proliferation of androgen-sensitive or estrogen-sensitive malignant cells in culture and in vivo. Int J Vitam Nutr Res 1997;67:164-170.
  10. Iwasaki T, Kurimoto S. Effect of methylcobalamin in accommodative dysfunction of eye by visual load. Sangyo Ika Daigaku Zasshi 1987;9:127-132.
  11. Uchiyama M, Mayer G, Okawa M, Meier-Ewert K. Effects of vitamin B12 on human circadian body temperature rhythm. Neurosci Lett 1995;192:1-4.
  12. Yoshioka K, Tanaka K. Effect of methylcobalamin on diabetic autonomic neuropathy as assessed by power spectral analysis of heart rate variations. Horm Metab Res 1995;27:43-44.
  13. Weinberg JB, Sauls DL, Misukonis MA, Shugars DC. Inhibition of productive human immunodeficiency virus-1 infection by cobalamins. Blood 1995;86:1281-1287.
  14. Hashimoto S, Kohsaka M, Morita N, et al. Vitamin B12 enhances the phase-response of circadian melatonin rhythm to a single bright light exposure in humans. Neurosci Lett 1996;220:129-132.
  15. Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993;103:149-157.
  16. Moriyama H, Nakamura K, Sanda N, et al. Studies on the usefulness of a long-term, high-dose treatment of methylcobalamin in patients with oligozoospermia. Hinyokika Kiyo 1987;33:151-156.
  17. Isoyama R, Kawai S, Shimizu Y, et al. Clinical experience with methylcobalamin (CH3-B12) for male infertility. Hinyokika Kiyo 1984;30:581-586.
  18. Tomoda A, Miike T, Matsukura M. Circadian rhythm abnormalities in adrenoleukodystrophy and methyl B12 treatment. Brain Dev 1995;17:428-431.
  19. Yamada N. Treatment of recurrent hypersomnia with methylcobalamin (vitamin B12): a case report. Psychiatry Clin Neurosci 1995;49:305-307.
  20. Ohta T, Ando K, Iwata T, et al. Treatment of persistent sleep-wake schedule disorders in adolescents with methylcobalamin (vitamin B12). Sleep 1991;14:414-418.



Copyright © 1995-2023 North American Pharmacal Inc ™ , Datapunk Informatics™, LLC. and Dr. Peter D'Adamo™ All rights reserved.